Latest Breaking News On - Cyprus based berhyanda - Page 1 : comparemela.com

Suven Pharma Q2 results: Net profit declines 5 3% YoY to Rs 74 72 crore

Suven Pharmaceuticals Ltd had reported a 12.2 percent year-on-year (YoY) rise in net profit at Rs 120.6 crore for the first quarter that ended June 30, 2023

Suven pharmaUnion cabinetSuven pharmaceuticalsCyprus based berhyandaHyderabad headquartered suvenSuven pharma q2 earningsUven pharma q2 resultsUven pharma q2 earnings updatesUven pharma q2 results updatesUven pharma quarterly resultsUven pharma q2 profitSuven pharma share priceUven pharma stocks priceUven pharma share price updatesUven pharma stock price updatesSuven pharma

Suven Pharma Q2 results: Net profit up 10% YoY to Rs 79 5 crore

Suven Pharmaceuticals Ltd had reported a 12.2 percent year-on-year (YoY) rise in net profit at Rs 120.6 crore for the first quarter that ended June 30, 2023

Suven pharmaUnion cabinetSuven pharmaceuticalsCyprus based berhyandaHyderabad headquartered suvenSuven pharma q2 earningsUven pharma q2 resultsUven pharma q2 earnings updatesUven pharma q2 results updatesUven pharma quarterly resultsUven pharma q2 profitSuven pharma share priceUven pharma stocks priceUven pharma share price updatesUven pharma stock price updatesSuven pharma

Cabinet approves Rs 9,589 cr FDI in Suven Pharmaceuticals by Cyprus-based firm

Cabinet approves Rs 9,589 cr FDI in Suven Pharmaceuticals by Cyprus-based firm
orissapost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orissapost.com Daily Mail and Mail on Sunday newspapers.

New delhiBerhyanda ltdSuven pharmaceuticalsCabinet committee on economic affairsCyprus based berhyandaCabinet committee

suven pharma share price: Suven Pharmaceuticals shares jump over 6% after cabinet approves Rs 9,589 crore FDI

According to the latest shareholding pattern available with the exchanges, as of 30 June 2023, 60% of the company s shareholding is with the promoter & promoter group, and 40% with the public.

Suven pharmaSuven pharmaceuticalsExchange board of indiaUnion cabinet onCabinet committee on economic affairsUnion cabinetCyprus based berhyandaHyderabad headquartered suvenCabinet committeeEconomic affairsReserve bankExchange boardSuven pharma share priceSuven pharma stock priceSuven pharma fdi investmentSuven pharma stock news

Suven Pharma shares hit 52-week high after Cabinet approves FDI worth Rs 9,589 crore

Suven Pharmaceuticals shares zoomed 8.53% to a fresh high of Rs 557.40 against the previous close of Rs 513.55 on BSE

Suven pharmaCabinet committee on economic affairsSuven pharmaceuticalsSuven pharmaceuticals ltdBerhyanda ltdCyprus based berhyandaCabinet committeeEconomic affairsShares of suven pharmaceuticalsDi in suven pharmaceuticalsDi in suven pharmaceuticalsRending stockUven pharmaceuticals shares in focusUven pharmaceuticals shares riseUven pharmaceuticals stock target priceUltibagger stock rises